Abstract | OBJECTIVE: To determine the long-term sequelae and early predictors of sequelae for children with Guillain-Barré syndrome (GBS) after the introduction of intravenous gammaglobulin ( IVIG). Study design A cross-sectional case series of children with GBS, at least 2 years after recovery, was performed. Manual muscle strength testing was done on 34 muscle groups. The functional independence measure was used to assess function. A chart review was completed, identifying acute factors that may predict long-term sequelae. RESULTS: Forty-seven children with GBS were identified, of whom 30 received IVIG. Persisting long-term muscle weakness with at least one muscle group at a grade 6 level (muscle moves the joint against gravity but only minimal resistance to an applied force) was found in 23% of cases. Each patient had a perfect score on the functional independence measure. Long-term muscle weakness was predicted by young age (P =.03) and a rapid progression to maximal weakness (P =.03). CONCLUSIONS: Despite the introduction of IVIG, 23% of children with GBS had evidence of long-term mild muscle weakness, with minimal impact on function. Young age and a rapid progression during the acute GBS period predicted long-term sequelae.
|
Authors | Jiri Vajsar, Darcy Fehlings, Derek Stephens |
Journal | The Journal of pediatrics
(J Pediatr)
Vol. 142
Issue 3
Pg. 305-9
(Mar 2003)
ISSN: 0022-3476 [Print] United States |
PMID | 12640380
(Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
|
Chemical References |
- Immunoglobulins, Intravenous
|
Topics |
- Activities of Daily Living
- Adolescent
- Child
- Child, Preschool
- Cross-Sectional Studies
- Female
- Follow-Up Studies
- Guillain-Barre Syndrome
(complications, therapy)
- Humans
- Immunoglobulins, Intravenous
(therapeutic use)
- Male
- Muscle Contraction
- Muscle Weakness
(diagnosis, etiology)
- Prognosis
- Risk Factors
|